The novel PI3K-δ inhibitor TGR-1202 enhances Brentuximab Vedotin-induced Hodgkin lymphoma cell death via mitotic arrest Academic Article uri icon

Overview

MeSH Major

  • Drug Resistance, Neoplasm
  • Lymphoma, Large-Cell, Anaplastic
  • NF-kappa B
  • Receptor Protein-Tyrosine Kinases
  • TNF Receptor-Associated Factor 1
  • Translocation, Genetic

publication date

  • December 2016

Research

keywords

  • Academic Article

Identity

Digital Object Identifier (DOI)

  • 10.1038/leu.2016.224

PubMed ID

  • 27499137

Additional Document Info

start page

  • 2402

end page

  • 2405

volume

  • 30

number

  • 12